Lubelski Wegiel Bogdanka SA
XMUN:UXX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lubelski Wegiel Bogdanka SA
XMUN:UXX
|
PL |
|
T
|
Teladoc Health Inc
F:4LL
|
US |
|
C
|
Conagra Brands Inc
XMUN:CAO
|
US |
|
V
|
Voya Financial Inc
F:V0Y
|
US |
|
M
|
MKS Instruments Inc
XMUN:MKT
|
US |
|
N
|
NWS Holdings Ltd
F:NWS
|
HK |
|
I
|
Innate Pharma SA
SWB:IDD
|
FR |
|
O
|
Oil States International Inc
SWB:OI2
|
US |
|
A
|
Ad Pepper Media International NV
XMUN:APM
|
DE |
|
Chewy Inc
F:3HH
|
US |
|
I
|
IDT Corp
XMUN:IDC2
|
US |
|
Grupo Mexico SAB de CV
F:4GE
|
MX |
|
L
|
Lagardere SA
DUS:LAG
|
FR |
|
I
|
IDT Corp
F:IDC2
|
US |
Wall St Price Targets
UXX Price Targets Summary
Lubelski Wegiel Bogdanka SA
According to Wall Street analysts, the average 1-year price target for UXX is 1.84 EUR with a low forecast of 1.82 EUR and a high forecast of 1.89 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is UXX's stock price target?
Price Target
1.84
EUR
According to Wall Street analysts, the average 1-year price target for UXX is 1.84 EUR with a low forecast of 1.82 EUR and a high forecast of 1.89 EUR.
What is the Revenue forecast for Lubelski Wegiel Bogdanka SA?
Projected CAGR
-7%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 7 years is -7%.
What is the Operating Income forecast for Lubelski Wegiel Bogdanka SA?
Projected CAGR
-14%
Over the last 13 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 7 years is -14%.
